December 6, 2018 / 12:40 PM / 7 days ago

BRIEF-Intellia Therapeutics And Novartis Expand Cell Therapy Collaboration

Dec 6 (Reuters) - Novartis AG:

* INTELLIA THERAPEUTICS AND NOVARTIS EXPAND CELL THERAPY COLLABORATION TO PURSUE CRISPR/CAS9-BASED GENOME EDITING IN ADDITIONAL STEM CELL POPULATION

* INTELLIA'S RIGHT TO USE PROPRIETARY LIPID NANOPARTICLE TECHNOLOGY EXTENDED TO ALL SETTINGS

* INTELLIA WILL RECEIVE A ONE-TIME $10 MILLION PAYMENT Further company coverage: (Reporting by Riham Alkousaa)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below